Top Stories
The software gives hospitals a three-day view of emerging staffing, bed and patient-flow pressures, while updating expected discharge dates every hour.
The company has submitted its 3D Intelligence algorithm to the FDA, offering users more flexibility based on their individual insulin needs.
The Swedish startup is expanding its AI medical assistant into an AI-native operating system for clinics, while doubling down on its presence across Europe.
Quicktome Deep Brain uses a patient’s own imaging to show where implanted leads sit and map the brain pathways around them, helping guide DBS surgery and follow-up programming.
The dataset will combine disease-specific genomes with treatment histories, pathology, imaging and patient outcomes, with general availability planned for mid-2027.
Conference News
VIENNA and SAN FRANCISCO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB), announced today that data from two r...
From Tissue to Answer: Integrated Solutions for Tissue and Molecular Pathology, from multiplex immunofluorescence to sample-to-result sequencing, powered by AISTOCKHOLM, Sept. 15, 2026 /PRNewswire/ --...
OXFORD, England, Sept. 14, 2026 /PRNewswire/ -- Albus Health today announced new findings from Leiden University Medical Centre showing that nocturnal cough, measured passively at home using the Albus...
RAD101 PET demonstrated 93% concordance with MRI across all evaluable lesions, meeting the trial's primary endpointMeeting with FDA planned on October 1st to align on RAD101Phase 3 pivotal trial proto...
Autoimmune diseases are characterized by high unmet medical need with most current treatments only addressing symptoms. Evaxion will apply AI-Immunology™ to target underlying pathologiesThe unique cap...
